Aradigm financial update

Following shareholder approval, Aradigm exchanged $9.1 million in an outstanding 5% promissory note issued to Novo Nordisk A/S (CSE:NVO; NYSE: NVO, Bagsvaerd, Denmark) for 26 million shares at $0.35....